UniProt ID | DYL1_HUMAN | |
---|---|---|
UniProt AC | P63167 | |
Protein Name | Dynein light chain 1, cytoplasmic | |
Gene Name | DYNLL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 89 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. Upon induction of apoptosis translocates together with BCL2L11 to mitochondria. | |
Protein Description | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures.; Binds and inhibits the catalytic activity of neuronal nitric oxide synthase.; Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1.; Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity.. | |
Protein Sequence | MCDRKAVIKNADMSEEMQQDSVECATQALEKYNIEKDIAAHIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAILLFKSG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Sumoylation | CDRKAVIKNADMSEE CCCCHHHCCCCCCHH | 39.21 | - | |
9 | Ubiquitination | CDRKAVIKNADMSEE CCCCHHHCCCCCCHH | 39.21 | - | |
9 | Acetylation | CDRKAVIKNADMSEE CCCCHHHCCCCCCHH | 39.21 | 23954790 | |
9 | Sumoylation | CDRKAVIKNADMSEE CCCCHHHCCCCCCHH | 39.21 | - | |
9 | Malonylation | CDRKAVIKNADMSEE CCCCHHHCCCCCCHH | 39.21 | 26320211 | |
13 | Sulfoxidation | AVIKNADMSEEMQQD HHHCCCCCCHHHHHH | 5.16 | 21406390 | |
14 | Phosphorylation | VIKNADMSEEMQQDS HHCCCCCCHHHHHHH | 30.84 | 25159151 | |
17 | Sulfoxidation | NADMSEEMQQDSVEC CCCCCHHHHHHHHHH | 3.68 | 30846556 | |
21 | Phosphorylation | SEEMQQDSVECATQA CHHHHHHHHHHHHHH | 18.58 | 29396449 | |
24 | S-nitrosylation | MQQDSVECATQALEK HHHHHHHHHHHHHHH | 4.68 | 21278135 | |
24 | Glutathionylation | MQQDSVECATQALEK HHHHHHHHHHHHHHH | 4.68 | 22555962 | |
24 | S-nitrosocysteine | MQQDSVECATQALEK HHHHHHHHHHHHHHH | 4.68 | - | |
26 | Phosphorylation | QDSVECATQALEKYN HHHHHHHHHHHHHCC | 26.49 | 29396449 | |
31 | Acetylation | CATQALEKYNIEKDI HHHHHHHHCCCHHHH | 44.43 | 25038526 | |
31 | Ubiquitination | CATQALEKYNIEKDI HHHHHHHHCCCHHHH | 44.43 | - | |
36 | Malonylation | LEKYNIEKDIAAHIK HHHCCCHHHHHHHHH | 51.11 | 26320211 | |
36 | Ubiquitination | LEKYNIEKDIAAHIK HHHCCCHHHHHHHHH | 51.11 | 21890473 | |
36 | Acetylation | LEKYNIEKDIAAHIK HHHCCCHHHHHHHHH | 51.11 | 19608861 | |
43 | Acetylation | KDIAAHIKKEFDKKY HHHHHHHHHHHHHHC | 36.06 | 26051181 | |
43 | Ubiquitination | KDIAAHIKKEFDKKY HHHHHHHHHHHHHHC | 36.06 | - | |
43 | Sumoylation | KDIAAHIKKEFDKKY HHHHHHHHHHHHHHC | 36.06 | 28112733 | |
43 | 2-Hydroxyisobutyrylation | KDIAAHIKKEFDKKY HHHHHHHHHHHHHHC | 36.06 | - | |
43 | Sumoylation | KDIAAHIKKEFDKKY HHHHHHHHHHHHHHC | 36.06 | - | |
44 | Acetylation | DIAAHIKKEFDKKYN HHHHHHHHHHHHHCC | 64.11 | 11921203 | |
44 | Ubiquitination | DIAAHIKKEFDKKYN HHHHHHHHHHHHHCC | 64.11 | - | |
48 | Ubiquitination | HIKKEFDKKYNPTWH HHHHHHHHHCCCCCE | 63.58 | - | |
49 | Sumoylation | IKKEFDKKYNPTWHC HHHHHHHHCCCCCEE | 52.70 | - | |
49 | Acetylation | IKKEFDKKYNPTWHC HHHHHHHHCCCCCEE | 52.70 | 25038526 | |
49 | Methylation | IKKEFDKKYNPTWHC HHHHHHHHCCCCCEE | 52.70 | 23644510 | |
49 | Ubiquitination | IKKEFDKKYNPTWHC HHHHHHHHCCCCCEE | 52.70 | 21906983 | |
49 | Sumoylation | IKKEFDKKYNPTWHC HHHHHHHHCCCCCEE | 52.70 | - | |
50 | Phosphorylation | KKEFDKKYNPTWHCI HHHHHHHCCCCCEEE | 31.92 | 28152594 | |
53 | Phosphorylation | FDKKYNPTWHCIVGR HHHHCCCCCEEEECC | 24.97 | 28857561 | |
56 | S-nitrosocysteine | KYNPTWHCIVGRNFG HCCCCCEEEECCCCH | 1.71 | - | |
56 | Glutathionylation | KYNPTWHCIVGRNFG HCCCCCEEEECCCCH | 1.71 | 22555962 | |
56 | S-nitrosylation | KYNPTWHCIVGRNFG HCCCCCEEEECCCCH | 1.71 | 19483679 | |
64 | Phosphorylation | IVGRNFGSYVTHETK EECCCCHHHCCCCHH | 16.58 | 28152594 | |
65 | Phosphorylation | VGRNFGSYVTHETKH ECCCCHHHCCCCHHH | 15.11 | 25159151 | |
67 | Phosphorylation | RNFGSYVTHETKHFI CCCHHHCCCCHHHHH | 13.03 | 25884760 | |
70 | Phosphorylation | GSYVTHETKHFIYFY HHHCCCCHHHHHHEE | 23.39 | 23186163 | |
88 | Phosphorylation | VAILLFKSG------ HHHHHHHCC------ | 42.26 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
88 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DYL1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Dynein light chain 1, a p21-activated kinase 1-interacting substrate,promotes cancerous phenotypes."; Vadlamudi R.K., Bagheri-Yarmand R., Yang Z., Balasenthil S.,Nguyen D., Sahin A.A., den Hollander P., Kumar R.; Cancer Cell 5:575-585(2004). Cited for: FUNCTION IN REGULATION OF BCL2L11, INTERACTION WITH PAK1 AND BCL2L11,PHOSPHORYLATION AT SER-88, AND MUTAGENESIS OF SER-88. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-65, AND MASSSPECTROMETRY. |